The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s veterinary active pharmaceutical ingredients manufacturing market report forecasts the veterinary active pharmaceutical ingredients manufacturing market size to grow to $9.11 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Forecast
The global veterinary active pharmaceutical ingredients manufacturing market is expected to grow from $6.37 billion in 2022 to $6.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary active pharmaceutical ingredients manufacturing market size is expected to grow to $9.11 billion in 2027 at a CAGR of 7.3%.

North America held the largest veterinary active pharmaceutical ingredients manufacturing market share.

Key Veterinary Active Pharmaceutical Ingredients Manufacturing Market Driver ­– Increase In Number Of Pet Owners
For instance, according to the South China Morning Post, a Hong Kong-based English-language newspaper, pet owners in China reached 62.94 million in 2020, up from 62.8 million in 2019. Therefore, increasing pet ownership is driving demand for the veterinary active pharmaceutical ingredients manufacturing market.

Request for A Sample Of The Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp

Key Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trend – Product Innovation
Major players in the market are focusing on innovative products to sustain their market positions. For instance, in June 2021, Lasa Supergenerics Limited, an India-based active pharmaceutical ingredient (API) manufacturing company, launched Oxyclozanide. Oxyclozanide is a novel anthelmintic that treats and manages fascioliasis, a topical worm infection in ruminants, primarily domestic animals like cattle (particularly buffalos on farms), goats, and sheep. Oxyclozanide is frequently used in the veterinary industry and has enormous potential in domestic and international markets.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segment
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, and NSAIDs
2) By Service Type: In-House, Contract Outsourcing
3) By Synthesis Type: Chemical-Based API, Biological API, Highly Potent API

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Major Players and Strategies
Major players in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group, Menadiona SL, Afton Pharma, Jiangsu Lingyun Pharmaceutical Co Limited, SUANFARMA, NGL Fine-Chem Limited, FIS Fabbrica Italiana Sintetici SpA, Lupin Limited, Aurobindo Pharma Limited, Albemarle Corporation, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, and Divi’s Laboratories Limited.

In June 2022, Orion Corporation, a Finland-based human and veterinary pharmaceutical industry, acquired Inovet (V.M.D. nv/sa) for an amount of $128.33 million (130 million euros). Through this acquisition, Orion’s Veterinary Medicines section will broaden its product portfolio and obtain a foothold in the production animal market, as well as extend its geographical footprint in Western Europe and the export market. Inovet (V.M.D. nv. sa.) is a Belgium-based manufacturer of veterinary active pharmaceutical ingredients.

The Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023 covers regional data on veterinary active pharmaceutical ingredients manufacturing market size, veterinary active pharmaceutical ingredients manufacturing market trends and drivers, opportunities, strategies, and veterinary active pharmaceutical ingredients manufacturing market competitor analysis. The countries covered in the veterinary active pharmaceutical ingredients manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Veterinary active pharmaceutical ingredients manufacturing refers to API synthesis from raw materials that necessitates multi-step methods using a range of high-tech processing technologies.

View More Reports Related To The Veterinary Active Pharmaceutical Ingredients Manufacturing Market –
Veterinary Medical Equipment Global Market Report 2023
Veterinary Patient Monitoring Equipment Global Market Report 2023
Pharmaceutical API Manufacturing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: